LETTER TO THE EDITOR
What is the role of admission HbA1c in managing COVID-19 patients?
入院糖化血红蛋白在新冠肺炎患者管理中的作用是什么?
Thirunavukkarasu Sathish,
Yingting Cao,
Corresponding Author
Thirunavukkarasu Sathish
Population Health Research Institute (PHRI), McMaster University, Hamilton, Ontario, Canada
Correspondence
Thirunavukkarasu Sathish, Population Health Research Institute (PHRI), McMaster University, Hamilton, ON L8L 2X2, Canada.
Email: [email protected]
Search for more papers by this authorYingting Cao
Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia
Search for more papers by this authorThirunavukkarasu Sathish,
Yingting Cao,
Corresponding Author
Thirunavukkarasu Sathish
Population Health Research Institute (PHRI), McMaster University, Hamilton, Ontario, Canada
Correspondence
Thirunavukkarasu Sathish, Population Health Research Institute (PHRI), McMaster University, Hamilton, ON L8L 2X2, Canada.
Email: [email protected]
Search for more papers by this authorYingting Cao
Non Communicable Disease Unit, Melbourne School of Population and Global Health, University of Melbourne, Parkville, Victoria, Australia
Search for more papers by this authorNo abstract is available for this article.
REFERENCES
- 1Ling P, Luo S, Zheng X, Cai G, Weng J. Elevated fasting blood glucose within the first week of hospitalization was associated with progression to severe illness of COVID-19 in patients with preexisting diabetes: a multicenter observational study. J Diabetes. 2020; 13: 89-93. https://doi.org/10.1111/1753-0407.13121.
- 2Lippi G, Sanchis-Gomar F, Henry BM. Response to: is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2020. https://doi.org/10.1111/1753-0407.13127.
- 3Bloomgarden Z. Does glycemic control affect outcome of COVID-19? J Diabetes. 2020; 12(12): 868-869.
- 4Apicella M, Campopiano MC, Mantuano M, Mazoni L, Coppelli A, Del Prato S. COVID-19 in people with diabetes: understanding the reasons for worse outcomes. Lancet Diabetes Endocrinol. 2020; 8(9): 782-792.
- 5Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2020; 17: 11–30. https://doi.org/10.1038/s41574-41020-00435-41574.
- 6Liu Z, Bai X, Han X, et al. The association of diabetes and the prognosis of COVID-19 patients: a retrospective study. Diabetes Res Clin Pract. 2020; 169:108386.
- 7Liu L, Wei W, Yang K, et al. Glycemic control before admission is an important determinant of prognosis in patients with coronavirus disease 2019. J Diabetes Investig. 2020. https://doi.org/10.1111/jdi.13431.
- 8Cariou B, Hadjadj S, Wargny M, et al. Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study. Diabetologia. 2020; 63(8): 1500-1515.
- 9Wang Z, Du Z, Zhu F. Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients. Diabetes Res Clin Pract. 2020; 164: 108214. https://doi.org/10.1016/j.diabres.2020.108214.
- 10Lee TF, Drake SM, Roberts GW, et al. Relative hyperglycemia is an independent determinant of in-hospital mortality in patients with critical illness. Crit Care Med. 2020; 48(2): e115-e122.
- 11Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke. 2001; 32(10): 2426-2432.
- 12Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355(9206): 773-778.
- 13Roberts GW, Quinn SJ, Valentine N, et al. Relative hyperglycemia, a marker of critical illness: introducing the stress hyperglycemia ratio. J Clin Endocrinol Metab. 2015; 100(12): 4490-4497.
- 14Luethi N, Cioccari L, Tanaka A, et al. Glycated hemoglobin A1c levels are not affected by critical illness. Crit Care Med. 2016; 44(9): 1692-1694.
- 15Sathish T, Kapoor N, Cao Y, Tapp RJ, Zimmet P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2020: In Press. https://doi.org/10.1111/dom.14269.
- 16Sathish T, Tapp RJ, Cooper ME, Zimmet P. Potential metabolic and inflammatory pathways between COVID-19 and new-onset diabetes. Diabetes Metab. 2020. https://doi.org/10.1016/j.diabet.2020.1010.1002.
- 17Li H, Tian S, Chen T, et al. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19. Diabetes Obes Metab. 2020; 22: 1897–1906. https://doi.org/10.1111/dom.14099.
- 18Singh AK, Singh R. Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract. 2020; 167: 108382. https://doi.org/10.1016/j.diabres.2020.108382.
- 19Sathish T, de Mello GT, Cao Y. Is newly diagnosed diabetes a stronger risk factor than pre-existing diabetes for COVID-19 severity? J Diabetes. 2020. https://doi.org/10.1111/1753-0407.13125.
- 20Sathish T, Cao Y. Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020. http://doi.org/10.1016/j.dsx.2020.12.024.
Citing Literature
